Blog
Will Adient (ADNT) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Adient (ADNT), which belongs to the Zacks
Will SSR Mining (SSRM) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider SSR Mining
Will Alarm.com (ALRM) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Alarm.com
Will ADP (ADP) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Automatic Data
Will Truist Financial (TFC) Beat Estimates Again in Its Next Earnings Report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Truist Financial Corporation (TFC)
Will Lamb Weston (LW) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Lamb Weston
Why United (UAL) is Poised to Beat Earnings Estimates Again
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider United
Why Exxon (XOM) Could Beat Earnings Estimates Again
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Exxon Mobil (XOM), which belongs to the
Will Blue Bird (BLBD) Beat Estimates Again in Its Next Earnings Report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Blue Bird (BLBD), which belongs to the
Should You Buy, Sell or Hold Honeywell Stock Post Aerospace Spin-Off?
Honeywell Technologies HON is in the headlines nowadays as it recently completed a strategic restructuring of its business to operate as a premier pure-play automation company.On June 29, the
Can NFG's Pipeline & Storage Expansion Projects Unlock Future Growth?
National Fuel Gas NFG is strengthening its pipeline network through pipeline and storage expansion projects and ongoing infrastructure modernization. These investments expand transportation
CEG Stock Trails Industry in the Past Year: Time to Buy, Hold or Sell?
Constellation Energy Corporation’s CEG shares have lost 24.4% over the past year against the Zacks Alternate Energy – Other industry’s growth of 21.7% and the Zacks Oil-Energy sector’s rally of
Can Caterpillar's Skycatch Deal Boost Its Mining Tech Edge?
Caterpillar Inc. CAT has strengthened its mining technology capabilities by acquiring Skycatch, Inc., a provider of spatial data capture, processing and analytics solutions for the mining industry
CytomX Therapeutics (CTMX) Upgraded to Buy: Here's Why
CytomX Therapeutics (CTMX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which
All You Need to Know About Live Oak Bancshares (LOB) Rating Upgrade to Buy
Live Oak Bancshares (LOB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which
Are You Looking for a Top Momentum Pick? Why LifeStance Health Group (LFST) is a Great Choice
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
PTC Therapeutics (PTCT) Upgraded to Strong Buy: Here's What You Should Know
PTC Therapeutics (PTCT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces
Omada Health, Inc. (OMDA) Is Up 7.18% in One Week: What You Should Know
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Neurocrine (NBIX) Upgraded to Strong Buy: What Does It Mean for the Stock?
Neurocrine Biosciences (NBIX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings
All You Need to Know About Veracyte (VCYT) Rating Upgrade to Strong Buy
Veracyte (VCYT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of
Here's Why Consensus Cloud Solutions, Inc. (CCSI) is a Great Momentum Stock to Buy
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Korro Bio, Inc. (KRRO) Upgraded to Buy: What Does It Mean for the Stock?
Investors might want to bet on Korro Bio, Inc. (KRRO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --
GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?
GoodRx Holdings, Inc. (GDRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces
Are You Looking for a Top Momentum Pick? Why Bioventus (BVS) is a Great Choice
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
All You Need to Know About Tarsus Pharmaceuticals (TARS) Rating Upgrade to Buy
Tarsus Pharmaceuticals, Inc. (TARS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings


